Publication | Closed Access
Assessment of clinical efficacy of CYT003‐QbG10 in patients with allergic rhinoconjunctivitis: a phase IIb study
141
Citations
25
References
2011
Year
Treatment with high-dose CYT003-QbG10 improved disease symptoms and reduced medication use in allergic individuals thus providing first evidence for a new potential immunotherapeutic.
| Year | Citations | |
|---|---|---|
Page 1
Page 1